Abstract:As one of the most studied ribonucleic acid (RNA) modifications in eukaryotes, N6 -methyladenosine (m6 A) has been shown to play a predominant role in controlling gene expression and influence physiological and pathological processes such as oncogenesis and tumor progression. Writer and eraser proteins, acting opposite to deposit and remove m6 A epigenetic marks, respectively, shape the cellular m6 A landscape, while reader proteins preferentially recognize m6 A modifications and mediate fate decision of the methylated RNAs, including RNA synthesis, splicing, exportation, translation, and stability. Therefore, RNA metabolism in cells is greatly influenced by these three classes of m6 A regulators. Aberrant expression of m6 A regulators has been widely reported in various types of cancer, leading to cancer initiation, progression, and drug resistance. The close links between m6 A and cancer shed light on the potential use of m6 A methylation and its regulators as prognostic biomarkers and drug targets for cancer therapy. Given the notable effects of m6 A in reversing chemoresistance and enhancing immune therapy, it is a promising target for combined therapy. Herein, we summarize the recent discoveries on m6 A and its regulators, emphasizing their influences on RNA metabolism, their dysregulation and impacts in diverse malignancies, and discuss the clinical implications of m6 A modification in cancer.

Regulation of telomere homeostasis and genomic stability in cancer by N 6 -adenosine methylation (m 6 A)

Regulation of Telomere Homeostasis and Genomic Stability in Cancer by N6-adenosine Methylation (M6a)

The emerging roles of N6-methyladenosine RNA methylation in human cancers

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

Retraction Note: RNA M 6 A Methylation Regulates the Epithelial Mesenchymal Transition of Cancer Cells and Translation of Snail

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

N 6 -Methyladenosine Modification-Mediated Mrna Metabolism is Essential for Human Pancreatic Lineage Specification and Islet Organogenesis

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

Function of N6-Methyladenosine Modification in Tumors

N6-Methyladenosine, DNA Repair, and Genome Stability

N6-methyladenosine regulates glycolysis of cancer cells through PDK4

Aberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer

Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

Regulation of m6A (N6-Methyladenosine) methylation modifiers in solid cancers

Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14.

The Evolving Landscape of N6-methyladenosine Modification in the Tumor Microenvironment.

N6-methyladenosine modification: a novel pharmacological target for anti-cancer drug development

The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance

The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance

N6-methyladenosine and its epitranscriptomic effects on hematopoietic stem cell regulation and leukemogenesis